Onxeo SA (Germany) Price Prediction
| C4X Stock | EUR 0.07 0.0001 0.14% |
Oversold Vs Overbought
48
Oversold | Overbought |
Using Onxeo SA hype-based prediction, you can estimate the value of Onxeo SA from the perspective of Onxeo SA response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Onxeo SA to buy its stock at a price that has no basis in reality. In that case, they are not buying Onxeo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Onxeo SA after-hype prediction price | EUR 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Onxeo |
Onxeo SA After-Hype Price Prediction Density Analysis
As far as predicting the price of Onxeo SA at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Onxeo SA or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Onxeo SA, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Onxeo SA Estimiated After-Hype Price Volatility
In the context of predicting Onxeo SA's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Onxeo SA's historical news coverage. Onxeo SA's after-hype downside and upside margins for the prediction period are 0.00 and 9.70, respectively. We have considered Onxeo SA's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Onxeo SA is out of control at this time. Analysis and calculation of next after-hype price of Onxeo SA is based on 3 months time horizon.
Onxeo SA Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Onxeo SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Onxeo SA backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Onxeo SA, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 9.63 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.07 | 0.07 | 0.85 |
|
Onxeo SA Hype Timeline
Onxeo SA is currently traded for 0.07on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Onxeo is estimated to decline in value after the next headline, with the price expected to drop to 0.07. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -0.85%, whereas the daily expected return is currently at 0.26%. The volatility of related hype on Onxeo SA is about 0.0%, with the expected price after the next announcement by competition of 0.07. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Onxeo SA recorded a loss per share of 0.11. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Onxeo SA Basic Forecasting Models to cross-verify your projections.Onxeo SA Related Hype Analysis
Having access to credible news sources related to Onxeo SA's direct competition is more important than ever and may enhance your ability to predict Onxeo SA's future price movements. Getting to know how Onxeo SA's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Onxeo SA may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 0QF | Moderna | 0.00 | 0 per month | 0.00 | (0.26) | 4.00 | (6.84) | 13.42 | |
| 22UA | BioNTech SE | 0.00 | 0 per month | 2.81 | 0.06 | 6.01 | (6.10) | 26.80 | |
| 8SP | Superior Plus Corp | 0.00 | 0 per month | 0.00 | (0.06) | 3.36 | (3.96) | 20.22 | |
| 2DG | SIVERS SEMICONDUCTORS AB | 0.00 | 0 per month | 0.00 | (0.14) | 9.09 | (10.00) | 52.42 | |
| TM9 | NorAm Drilling AS | 0.00 | 0 per month | 4.21 | (0.01) | 5.56 | (6.43) | 36.50 | |
| NOH1 | Norsk Hydro ASA | 0.00 | 0 per month | 1.77 | 0.07 | 6.61 | (3.25) | 12.96 | |
| RS6 | Reliance Steel Aluminum | 0.00 | 0 per month | 1.16 | 0.08 | 2.94 | (2.03) | 13.65 | |
| XYTA | CHINA HUARONG ENERHD 50 | 0.00 | 0 per month | 8.11 | 0.13 | 33.33 | (20.00) | 233.33 | |
| 9K1 | NORDIC HALIBUT AS | 0.00 | 0 per month | 0.00 | (0.21) | 2.94 | (4.62) | 14.80 | |
| 3RKU | RYOHIN UNSPADR1 | 0.00 | 0 per month | 1.49 | 0.09 | 3.25 | (2.50) | 9.52 |
Onxeo SA Additional Predictive Modules
Most predictive techniques to examine Onxeo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Onxeo using various technical indicators. When you analyze Onxeo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Onxeo SA Predictive Indicators
The successful prediction of Onxeo SA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Onxeo SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Onxeo SA based on analysis of Onxeo SA hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Onxeo SA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Onxeo SA's related companies.
Story Coverage note for Onxeo SA
The number of cover stories for Onxeo SA depends on current market conditions and Onxeo SA's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Onxeo SA is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Onxeo SA's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Onxeo SA Short Properties
Onxeo SA's future price predictability will typically decrease when Onxeo SA's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Onxeo SA often depends not only on the future outlook of the potential Onxeo SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Onxeo SA's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.7 M |
Complementary Tools for Onxeo Stock analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |